Thursday, 15 October 2026European Markets

PAYTON PLANAR, GLINTT, Another 2 Companies Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - payton planar (pay.br) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
payton planar (pay.br) €8.00 6.86% 21.92%
glintt (glint.ls) €0.47 4.78% 5.11%
wavestone (wave.pa) €56.10 0.72% 13.46%
dassault systemes (dsy.pa) €41.04 0.67% 13.75%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. payton planar (pay.br)

6.86% forward dividend yield and 21.92% return on equity

payton planar magnetics ltd., together with its subsidiaries, engages in development, manufacture, and marketing of planar and conventional transformers worldwide. the company provides various planar transformers; inductors, including common mode chocks; and off the shelf smt planar transformers. it also supplies planar magnetic solutions. the company serves telecom/datacenter, automotive companies, industrial, and medical companies. payton planar magnetics ltd. was incorporated in 1992 and is based in ness ziona, israel. the company is a subsidiary of payton industries ltd.

earnings per share

as for profitability, payton planar has a trailing twelve months eps of €0.82.

pe ratio

payton planar has a trailing twelve months price to earnings ratio of 9.76. meaning, the purchaser of the share is investing €9.76 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.92%.

more news about payton planar.

2. glintt (glint.ls)

4.78% forward dividend yield and 5.11% return on equity

glintt - global intelligent technologies, s.a. provides it consulting services for banking, insurance, public administration, and utilities sectors in portugal, spain, and angola. it operates through two segments: health and other markets. the company engages in the sale of equipment, furniture, consumables, and robotics solutions; development of architectural projects; and design and conception of lay-out and image for pharmacies, training, equipment maintenance, and consultancy projects. it licenses proprietary software solutions for healthcare providers, such as clinics, hospitals, pharmacies, and other bodies of the ministry of health; and develops, implements, and maintains software services for the health sector. in addition, the company implements erps, integrates internet systems, and develops tailor-made applications services. further, the company develops, implements, and integrates partner platforms with emphasis on the bpm, erp, bi and mobility solutions; and integrates it infrastructures, as well as support for networking, security, storage systems, and database management. glintt - global intelligent technologies, s.a. was incorporated in 1995 and is based in sintra, portugal. glintt - global intelligent technologies, s.a. operates as a subsidiary of farminveste - investimentos, participações e gestão s.a.

earnings per share

as for profitability, glintt has a trailing twelve months eps of €0.05.

pe ratio

glintt has a trailing twelve months price to earnings ratio of 9.4. meaning, the purchaser of the share is investing €9.4 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.11%.

more news about glintt.

3. wavestone (wave.pa)

0.72% forward dividend yield and 13.46% return on equity

wavestone sa provides technology consulting services primarily in france and internationally. it offers consulting services in the areas of financial services, manufacturing, retail and consumer goods, luxury, energy and utilities, transport and services, and government and international institutions. the company was formerly known as solucom sa and changed its name to wavestone sa in july 2016. wavestone sa was incorporated in 1990 and is headquartered in paris, france.

earnings per share

as for profitability, wavestone has a trailing twelve months eps of €2.77.

pe ratio

wavestone has a trailing twelve months price to earnings ratio of 20.25. meaning, the purchaser of the share is investing €20.25 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.46%.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on jul 31, 2024, the estimated forward annual dividend rate is 0.38 and the estimated forward annual dividend yield is 0.72%.

volume

today's last reported volume for wavestone is 10775 which is 11.82% below its average volume of 12220.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, wavestone's stock is considered to be overbought (>=80).

more news about wavestone.

4. dassault systemes (dsy.pa)

0.67% forward dividend yield and 13.75% return on equity

dassault systèmes se provides software solutions and services worldwide. it offers solidworks provides easy-to-use 2d and 3d product development solutions accessible to any business; catia, an engineering and design software for product 3d computer-aided design; geovia for intersection of natural resources, infrastructure, and urban planning; and biovia that develops chemicals, biologics, and materials experiences. the company provides simulia that delivers realistic simulation applications; delmia, which enables global industrial operations; 3dvia that provides 3d space planning solutions; and enovia that enables to plan and track the definition of success for customer. in addition, it offers centric plm, a product lifecycle management software solution; 3dexcite, a real-time 3d visualization software; netvibes, which enables organizations to gather, align, and enrich big data; 3dexperience platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and medidata, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. the company distributes its products through direct and indirect sales channels. it primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; infrastructure, energy, and materials; home and lifestyle; architecture, engineering, and construction; cities, and public services; consumer packaged goods and retail; marine and offshore; and business services. dassault systèmes se was incorporated in 1981 and is headquartered in vélizy-villacoublay, france.

earnings per share

as for profitability, dassault systemes has a trailing twelve months eps of €0.79.

pe ratio

dassault systemes has a trailing twelve months price to earnings ratio of 51.95. meaning, the purchaser of the share is investing €51.95 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.75%.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on may 27, 2024, the estimated forward annual dividend rate is 0.23 and the estimated forward annual dividend yield is 0.67%.

more news about dassault systemes.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com